Company investing in new genetics, and
micropropagation with Segra as part of its commitment to continuous
improvement in product quality
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to announce the
launch of three new strains of Edison Cannabis Co. (“Edison”) dried
flower products, including higher tetrahydrocannabinol (THC)
options The General (Grapefruit GG4), Chemdog and limited time
option Samurai Spy (Ninja Fruit).
Available sales data continues to reinforce that cannabis
consumers want both high THC dried flower products and cultivar
diversity.
“At Organigram, we are keeping a keen eye on the evolution of
market preferences and feedback from cannabis consumers,” says
Engel. “Consumers have indicated that high quality, value pricing
and higher THC options are important to them and we are proud to be
able to respond to that demand.”
Each of the new Edison strains benefits from being grown in
data-backed, strain-specific grow rooms with customized
micro-climates designed to ensure consistent quality. Likewise,
each Edison flower is packed with the Company’s dual boost humidity
pack to preserve freshness.
The three strains are The General (Grapefruit GG4), Chemdog, and
Samurai Spy (Ninja Fruit).
The General (Grapefruit GG4)
Edison’s sativa dominant The General (Grapefruit GG4) can
generally be identified by its vivid green buds, tangerine pistils,
grapefruit undertones and citrusy gasoline aroma. This strain
features 17% - 24% THC and its terpene profile includes
Terpinolene, Limonene, Myrcene, and Pinene.
Chemdog
Chemdog is a hybrid from Edison that boasts berry and floral
notes, a spicy citrus undertone, fruity aroma, violet-green buds
and a tall tapered, trichome covered flower. This strain features
18-25% THC and its terpene profile includes Limonene,
Caryophyllene, Linalool, and Myrcene.
Samurai Spy (Ninja Fruit)
Samurai Spy (Ninja Fruit) from Edison is a hybrid characterized
by its sweet grape flavour, piney notes, spicy aroma, crimson
pistils and glistening lavender-jade buds. This strain features 17%
- 24% THC and its terpene profile includes Caryophyllene, Myrcene,
Limonene and Pinene.
The General (Grapefruit GG4) and Chemdog are currently being
rolled out to retailers across the country.
Samurai Spy (Ninja Fruit) will be available soon in select
provinces and for a limited time only.
Exploring New Cultivars, Micropropagation
In an ongoing effort to optimize the potential of the Company’s
core cultivars and bring novel cultivars to market, Organigram is
working with Segra International Corp. (“Segra”), a Canadian
cannabis ag-tech company and pioneer in both cannabis plant tissue
culture (also known as micropropagation) and cannabis genomics.
While growing cuttings to generate clones from a mother stock
plant is the standard practice for young plant propagation
historically, micropropagation creates true-to-type disease-free
plants that offer improved quality, standardization, and
reliability for cannabis young plant production.
“Our plant tissue culture technology represents a new frontier
of optimized cannabis cultivation,” says Jamie Blundell, CEO at
Segra. “As companies continue to strive to improve their bottom
line, the adoption of plant tissue culture at scale will be key to
both reducing operational risks and improved financial performance.
Partners like Organigram who increasingly embrace plant tissue
culture will find that they are not only strengthening their young
plants but the wellness and productivity of their entire operation
down stream.”
Plant tissue culture technology has the ability to unlock the
full potential of cannabis plants, rejuvenating them back to a
disease-free “generation-zero” version of the plant with optimized
performance. Likewise, plant tissue culture allows propagators to
select desirable variants and scale up viable cultivars more
rapidly.
“Achieving the peak performance of our plants is at the core of
our business,” says Engel. “We are proud to work with innovators
like Segra who help us both deliver unique product offerings to our
customers and help ensure our portfolio of plants is strong and
productive for generations to come.”
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics and Trailblazer.
Organigram's facility is located in Moncton, New Brunswick and the
Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors that change consumer preferences; factors that impact plant
cultivars and tissue culture; future product offerings; competitive
conditions; including general risks related to COVID-19 and risks
as disclosed in the Company’s most recent annual information form,
management’s discussion and analysis and other Company documents
filed from time to time on SEDAR (see www.sedar.com) and filed or
furnished to the Securities and Exchange Commission on EDGAR (see
www.sec.gov). Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. Although the Company believes that the
assumptions and factors used in preparing the forward-looking
information in this news release are reasonable, undue reliance
should not be placed on such information and no assurance can be
given that such events will occur in the disclosed time frames or
at all. The forward-looking information included in this news
release are made as of the date of this news release and the
Company disclaims any intention or obligation, except to the extent
required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
About Segra International
Segra is an agriculture technology company offering plant tissue
culture and DNA fingerprinting services to accelerate the
advancement of the cannabis industry. The Company’s proprietary
technologies empower its clients to drive financial performance and
mitigate risk, while exploring the next frontier of optimized
cultivation practices for the rapidly evolving cannabis consumer.
Segra has developed industrial-scale laboratories to produce
disease-free, robust, and DNA-fingerprinted cannabis plantlets for
licensed producers globally. To support this vision, Segra has
assembled a world-class team of specialists in the fields of
agronomy, molecular genetics, plant tissue culture, and regulatory
compliance. Learn more at www.segra-intl.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200804005288/en/
For Investor Relations enquiries, please contact: Amy Schwalm
Vice President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057
For Media enquiries, please contact: Marlo Taylor
mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024